Search - tctmd.com

Displaying 281 - 300 of 302

Sort: Relevancy | Date

News Conference News TCT 2012

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

Presenter: David Morrow

October 23, 2012

Presentation TCT 2012

CABG Will Always Be the Preferred Approach!

Presenter: Friedrich Mohr

October 23, 2012

Presentation TCT 2012

CABG Today Is Under-Utilized!

Presenter: Michael Mack

October 23, 2012

Presentation TCT 2012

CABG Today Is Over-Utilized!

Presenter: William Fearon

October 23, 2012

Presentation TCT 2012

CABG Plus PCI for MVD: The Hybrid Option

Presenter: David Zhao

October 23, 2012

Presentation TCT 2012

3 Cases of Increasing Clinical and Anatomic Complexity

Presenter: Kendra Grubb

October 23, 2012

Presentation TCT 2012

Utility of Scoring Systems in High Risk PCI Stratification

Presenter: Davide Capodanno

October 22, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

Presentation TCT 2012

How to Choose Between CABG and PCI in Complex CAD: A Practical Approach

Presenter: Gennaro Sardella

October 22, 2012

Presentation TCT 2012

Case 3: An Unusual Complication

Presenter: Luigi Salemme

October 22, 2012

Presentation TCT 2012

Case 1: Complex CAD: CABG or PCI?

Presenter: Murat Cayli

October 22, 2012

Presentation TCT 2012

Predictive value of EuroSCORE derived parameters for the development of right ventricular failure after cardiac surgery

Presenter: Annemarie Engstrom, Wim K. Lagrand, Kim W. van der Sloot, Wadim de Boon, Jos A. van der Sloot, Jan J. Piek, Dagmar M. Ouweneel, Jaap J. Kloek, Jan G. Tijssen, Bas A. de Mol, Jose P. Henriques

January 03, 2012

$Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...$

Presentation TCT 2012

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Presenter: Shyam Poludasu, Usman Baber, Chabbra Sandeep, Jennifer Yu, Rebecca Pinnelas, Avery E. Clark, Roxana Mehran, George Dangas, Annapoorna S. Kini, Samin K. Sharma

January 03, 2012

Presentation TCT 2012

CAN POTENTIALLY SIGNIFICANT COMPETITIVE FLOW BE IDENTIFIED AT THE TIME OF CABG?

Presenter: T. Bruce Ferguson, Cheng Chen

January 03, 2012

News Conference News

Advertisement

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

CABG Will Always Be the Preferred Approach!

CABG Today Is Under-Utilized!

CABG Today Is Over-Utilized!

CABG Plus PCI for MVD: The Hybrid Option

3 Cases of Increasing Clinical and Anatomic Complexity

Utility of Scoring Systems in High Risk PCI Stratification

Review of TAVR Use Offers Significant Advances, Positive Outcomes

How to Choose Between CABG and PCI in Complex CAD: A Practical Approach

Case 3: An Unusual Complication

Case 1: Complex CAD: CABG or PCI?

Predictive value of EuroSCORE derived parameters for the development of right ventricular failure after cardiac surgery

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

CAN POTENTIALLY SIGNIFICANT COMPETITIVE FLOW BE IDENTIFIED AT THE TIME OF CABG?

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

Caution Urged in Widespread Adoption of TAVR

SYNTAX at 4 Years: PCI and CABG Equivalent in Left Main Disease

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

SAPPHIRE and CABANA Add More Validation for Carotid Artery Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content